© 2021 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Paul Gillette is a freelance writer based in Euclid, Ohio.
May 30, 2012
Suneva Medical has acquired a new product line, including worldwide rights to Refissa (tretinoin 0.05 percent), from Spear Pharmaceuticals.
A person’s eye color may help to predict risk for vitiligo, according to results of a new study.
A new study shows that a hormone that is associated with maintaining bone health may also help to boost antimicrobial peptide (AMP) expression when dietary vitamin D levels are low.
Scientists have taken skin cells from patients with advanced heart failure and used them to create healthy, patient-specific heart muscle cells, according to results of a recent study.
New research suggests aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) may help protect against skin cancer.
Another recent study has shown that the BRAF inhibitor dabrafenib is safe and effective in treating advanced melanoma.
May 23, 2012
Swiss drugmaker Novartis has signed an agreement to acquire Fougera Pharmaceuticals for more than $1.5 billion in cash.
Data from an ongoing clinical evaluation of a combination of two drugs in patients with advanced melanoma is showing promise as a new way of treating the disease.
A recently published study suggests vigorous exercise may be associated with a lower risk of psoriasis.
A watchdog organization has released a report indicating more than 50 percent of tested sunscreens contain ingredients that have the potential to cause cell damage and skin cancer.